skip to content

Transmissible Cancer Group

 
Karina

We use genetic and molecular methods to understand the origins, evolution, disease dynamics and host interactions of DFT1, DFT2 and CTVT. We also study genetic factors influencing host susceptibility, disease pathogenesis and treatment responses. We aim to understand how DFT1, DFT2 and CTVT have emerged and adapted to their hosts with the goal develop methods to prevent or control these diseases, and to gain general insights into cancer evolution and pathogen dynamics.

If you are a vet who is familiar with CTVT, please get involved in our research!

Our research is supported by Wellcome.

Mo Tu We Th Fr Sa Su
 
 
 
 
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 
11
 
12
 
13
 
14
 
15
 
16
 
17
 
18
 
19
 
20
 
21
 
22
 
23
 
24
 
25
 
26
 
27
 
28
 
29
 
30
 
31